Celldex Therapeutics
CLDX
#4723
Rank
HK$15.06 B
Marketcap
HK$226.78
Share price
-1.59%
Change (1 day)
9.60%
Change (1 year)

Celldex Therapeutics (CLDX) Fails to deliver data

Key failure to deliver metrics for Celldex Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Celldex Therapeutics (CLDX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Celldex Therapeutics (CLDX) - since 2019

Volume in USD (price x number of shares), data since 2019

Celldex Therapeutics (CLDX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025HK$11.28 M99.68%
2024HK$5.65 M43.21%
2023HK$3.94 M-85.8%
2022HK$27.79 M-36.31%
2021HK$43.63 M146.97%
2020HK$17.66 M1075.04%
2019HK$1.5 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Seagen
SGEN
N/AHK$3.02 M๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$0.39 MHK$3.49 M๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$1.89 MHK$4.32 M๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$5.75 MHK$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$24.63 MHK$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$72.01 MHK$0.40 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
HK$0.09 MHK$0.36 M๐Ÿ‡บ๐Ÿ‡ธ USA